UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 12, 2005
Lifecore Biomedical, Inc.
(Exact name of Registrant as specified in its charter)
| | | | |
Minnesota | | 0-4136 | | 41-0948334 |
(State or other jurisdiction of | | (Commission File Number) | | (IRS Employer Identification No.) |
incorporation or organization) | | | | |
| | |
3515 Lyman Boulevard | | |
Chaska, Minnesota | | 55318 |
(Address of principal executive | | (Zip Code) |
offices) | | |
Registrant’s telephone number, including area code:952-368-4300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 2.02 Results of Operation and Financial Condition
On October 12, 2005, Lifecore Biomedical, Inc. (“Lifecore”) issued a press release setting forth Lifecore’s Fiscal 2006 first quarter financial results. A copy of Lifecore’s press release is attached hereto as Exhibit (99.1) and hereby incorporated by reference.
Item 9.01 Financial Statements and Exhibits
(c) The following exhibit is being furnished herewith:
99.1 | | Press release dated October 12, 2005 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| | LIFECORE BIOMEDICAL, INC. |
|
Dated: October 12, 2005 | | /s/ Dennis J. Allingham |
| | Dennis J. Allingham |
| | President & Chief Executive Officer |
Exhibit Index
99.1 | | Press release dated October 12, 2005 |